Familial seropositive rheumatoid arthritis in North American native families: Effects of shared epitope and cytokine genotypes

Journal of Rheumatology

Volumn 32, Issue 6, 2005, Pages 983-991

  Oen, Kiem ^a   Robinson, David B ^b   Nickerson, Peter ^b   Katz, Steven J ^a   Cheang, Mary ^a   Peschken, Christine A ^b   Canvin, Janice M G ^b   Hitchon, Carol A ^a   Schroeder, Marial Louise ^a   El Gabalawy, Hani S ^a  

^a Department of Paediatrics and Child Health ^*

^b ASTRAZENECA   (United Kingdom)

Author keywords

Cytokine genes; Genetics; North American native; Rheumatoid arthritis

Indexed keywords

CYTOKINE; EPITOPE; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; RHEUMATOID FACTOR;

ADOLESCENT; ADULT; AMERICAN INDIAN; ARTICLE; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; FAMILIAL DISEASE; FAMILIAL INCIDENCE; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PEDIGREE; POLYARTHRITIS; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR;

EID: 20444499370     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Seidin MF, Amos CI, Ward R, Gregersen PK. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 1999;42:1071-9.
2. Silman AJ. Rheumatoid arthritis. In: Silman AJ, Hochberg MC, editors. Epidemiology of the rheumatic diseases. 2nd ed. Oxford: Oxford University Press; 2001:31-71.
3. MacGregor AJ, Snieder H, Rigby AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis. Arthritis Rheum 2000;43:30-7.
4. Deighton CM, Walker DJ, Griffiths ID, Roberts FD. The contribution of HLA to rheumatoid arthritis. Clin Genet 1989;36:178-82.
5. Rigby AS, Silman AJ, Voelm L, et al. Investigating the HLA component in rheumatoid arthritis: An additive (dominant) mode of inheritance is rejected, a recessive mode is preferred. Genet Epidemiol 1991;8:153-75.
6. Cantagrel A, Navaux F, Loubet-Lescoulie P, et al. Interleukin-1β, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms. Relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 1999;42:1093-100.
7. Khani-Hanjani A, Lacaille D, Hoar D, et al. Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis. Lancet 2000;356:820-5.
8. Crilly A, Bartlett JMS, White A, Stirling D, Capell H, Madhok R. Investigation of novel polymorphisms within the 3′ region of the IL-6 gene in patients with rheumatoid arthritis using genescan analysis. Cytokine 2001;13:109-12.
9. Mulcahy B, Waldron-Lynch F, McDermott MF, et al. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet 1996;59:676-83.
10. Mu H, Chen JJ, Jiang Y, King M-C, Thomson G, Criswell LA. Tumor necrosis factor a microsatellite polymorphism is associated with rheumatoid arthritis severity through an interaction with the HLA-DRB1 shared epitope. Arthritis Rheum 1999;42:438-42.
11. Martinez A, Fernandez-Arquero M, Pascual-Salcedo D, et al. Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis. Arthritis Rheum 2000;43:1366-70.
12. Sugiura Y, Niimi T, Sato S, et al. Transforming growth factor β gene polymorphism in rheumatoid arthritis. Ann Rheum Dis 2002;61:826-8.
13. Vanasco J, Beraun Y, Nieto A, et al. Polymorphism at the TNFa loci in rheumatoid arthritis. Tissue Antigens 1997;49:74-8.
14. Meyer JM, Han J, Moxley M. Tumor necrosis factor markers show sex-influenced association with rheumatoid arthritis. Arthritis Rheum 2001;44:286-95.
15. Wilson AG, de Vries N, van de Putte LBA, Duffe GW. A tumour necrosis factor a polymorphism is not associated with rheumatoid arthritis. Ann Rheum Dis 1995;54:601-3.
16. Brinkman BMN, Huizinga TWJ, Kurban SS, et al. Tumour necrosis factor a gene polymorphisms in rheumatoid arthritis: Association with susceptibility to, or severity of, disease? Br J Rheumatol 1997;36:516-21.
17. Ollier WER. Role of interferon-γ gene in rheumatoid arthritis? Lancet 2000;356:783-4.
18. Constantin A, Navaux F, Lauwers-Cances V, et al. Interferon gamma gene polymorphism and susceptibility to, and severity of, rheumatoid arthritis. Lancet 2001;358:2051-2.
19. Pokorny V, Chau J, Wu L, et al. Transforming growth factor β gene (HSTGFB1) nucleotide T869C (codon 10) polymorphism is not associated with prevalence or severity of rheumatoid arthritis in a Caucasian population. Ann Rheum Dis 2003;62:907-8.
20. Peschken CA, Esdaile JM. Rheumatic diseases in North America's indigenous peoples. Semin Arthritis Rheum 1999;28:368-91.
21. Rothschild BM, Woods RJ, Rothschild C, Sebes JI. Geographic distribution of rheumatoid arthritis in ancient North America: Implications for pathogenesis. Semin Arthritis Rheum 1992;22:181-7.
22. Boyer GS, Templin DW, Lannier AP. Rheumatic diseases in Alaskan Indians of the southeast coast: high prevalence of rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 1991;18:1477-84.
23. Del Puente A, Knowler WC, Pettitt DJ, Bennett PH. High incidence and prevalence of rheumatoid arthritis in Pima Indians. Am J Epidemiol 1989;129:1170-8.
24. Willkens RF, Nepom GT, Marks CR, Nettles JW, Nepom BS. Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Arthritis Rheum 1991;34:43-7.
25. Beasley RP, Willkens RF, Bennett PH. High prevalence of rheumatoid arthritis in Yakima Indians. Arthritis Rheum 1973;16:743-8.
26. Harvey J, Lotze M, Stevens MB, Lambert G, Jacobson D. Rheumatoid arthritis in a Chippewa band. I. Pilot screening study of disease prevalence. Arthritis Rheum 1981;24:717-21.
27. Peschken CA, El-Gabalawy HS, Roos L, Esdaile JM. Algonkian Indians have twice the frequency of rheumatoid arthritis with a younger age of onset [abstract]. Arthritis Rheum 1998;41 Suppl:S125.
28. Wordsworth P, Bell J. Polygenic susceptibility in rheumatoid arthritis. Ann Rheum Dis 1991;50:343-6.
29. Lynn AH, Kwoh CK, Venglish CM, Aston CE, Chakravarti A. Genetic epidemiology of rheumatoid arthritis. Am J Hum Genet 1995;57:150-9.
30. Oen K, Schroeder MJ, Jacobson K, et al. Juvenile rheumatoid arthritis in a Canadian First Nations (aboriginal) population: Onset subtypes and HLA associations. J Rheumatol 1998;25:783-90.
31. Oen K, El-Gabalawy HS, Canvin JMG, et al. HLA associations of seropositive rheumatoid arthritis in a Cree and Ojibway population. J Rheumatol 1998;25:2319-23.
32. Arnett FC, Edworthy ST, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
33. Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban 1997. J Rheumatol 1998;25:1991-4.
34. Fries JF, Spitz P, Kraines G, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
35. Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology. 4th ed. Philadelphia: W.B. Saunders Company; 2000:236-69.
36. Lu KC, Jaramillo A, Lecha RL, et al. Interleukin-6 and interferon-γ gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2002;74:1297-302.
37. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-9.
38. Guo Z, Binswanger U, Knoflach A. Role of codon 10 and codon 25 polymorphisms on TGF-β1 gene expression and protein synthesis in stable renal allograft recipients. Transplant Proc 2002;34:2904-6.
39. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-β1 gene: Association with transforming growth factor-β1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998;66:1014-20.
40. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenetics 1997;24:1-8.
41. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999;42:1101-8.
42. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-76.
43. Hajeer AH, Lazarus M, Turner D, et al. IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand J Rheumatol 1998;27:142-5.
44. Lard LR, van Gaalen FA, Schonkeren JJM, et al. Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis. Arthritis Rheum 2003;48:1841-8.
45. Huizinga TWJ, Keijers V, Yanni G, et al. Are differences in interleukin 10 production associated with joint damage? Rheumatology Oxford 2000;39:1180-8.
46. Eksdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RGJ. Huizinga TWJ. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998;95:9465-70.
47. National Center for Biotechnology Information (NCBI). Single Nucleotide Polymorphism Database, dbSNP, Bethesda, MD: NCBI; Last update date June 9, 2004. Access date December 14, 2004. Available from: http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?db=snp
48. Griffiths AJ, Miller JH, Suzuki DI, Lewontin RC, Gelbart WM. An introduction to genetic analysis. 7th ed. New York: W.H. Freeman and Company; 1999: Box 24-1 (electronic version). Access date December 6, 2004.
49. Bias WB, Hsu SH, Pollard MK, et al. HLA-DR characterization of a Chippewa Indian subpopulation with high prevalence of rheumatoid arthritis. Human Immunol 1981;2:155-63.
50. Templin DW, Boyer GS, Lanier AP, et al. Rheumatoid arthritis in Tlingit Indians: Clinical characterisation and HLA associations. J Rheumatol 1994;21:1238-44.
51. Nelson JL, Boyer G, Templin D, et al. HLA antigens in Tlingit Indians with rheumatoid arthritis. Tissue Antigens 1992;40:57-63.
52. Williams RC, Jacobsson LTH, Knowler WC, et al. Meta-analysis reveals association between most common Class II haplotype in full-heritage native Americans and rheumatoid arthritis. Human Immunol 1995;42:90-4.
53. Radstake TRDJ, Barrera P, Albers MJC, Swinkels HL, van de Putte LBA, van Riel PLCM. Genetic anticipation in rheumatoid arthritis in Europe. J Rheumatol 2001;28:962-7.
54. McDermott E, Khan MA, Deighton C. Further evidence for genetic anticipation in familial rheumatoid arthritis. Ann Rheum Dis 1996;55:475-7.
55. Warle MC, Farhan A, Metselaar HJ, et al. Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl 2003;9:170-81.
56. Gibson AW, Edberg JC, Wu J, Westendorp RGJ, Huizinga TWJ, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001;166:3915-22.
57. Barrera P, Faure S, Prud'homme JF, et al. European genetic study on rheumatoid arthritis: Is there a linkage of the interleukin-1 (IL-1), IL-10 or IL-4 genes to RA? Clin Exp Rheumatol 2001;19:709-14.
58. Eksdale J, McNicholl J, Wordsworth P, et al. Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility. Lancet 1998;352:1282-3.